Article | March 25, 2026

9 Pillars Of Inspection Readiness For GMP Manufacturers: A Practical CSA Playbook

Inspection readiness

Scrambling for records, chasing down technicians, and assembling asset history by hand point to a system problem, not an inspection problem. With FDA's risk-based enforcement and continued attention to data integrity, readiness has to be a standing condition. This framework (the author's own, not an official FDA model) sorts inspection readiness into nine pillars that correspond to areas inspectors actually examine. They run from leadership and CAPA maturity, through process, facility, equipment, and lab controls, to how people and mock audits perform under pressure. Throughout, it singles out where maintenance, calibration, and asset records weigh most heavily, and it links to a self-assessment for benchmarking your current state. Explore the nine pillars to see where your program stands.

Access The Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online